US HB3821 | 2025-2026 | 119th Congress

Status

Sponsorship: Slight Partisan Bill (Democrat 13-8)
Status: Introduced on June 6 2025 - 25% progression
Action: 2025-06-06 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

ADINA Act Allergen Disclosure In Non-food Articles Act

Sponsors


History

DateChamberAction
2025-06-06HouseReferred to the House Committee on Energy and Commerce.
2025-06-06HouseSponsor introductory remarks on measure. (CR H2516)
2025-06-06HouseIntroduced in House

Subjects


US Congress State Sources


feedback